
        <!DOCTYPE html>
        <html>
        <head>
            <title>COMPASS Pathways plc (CMPS) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">COMPASS Pathways plc (CMPS)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">22</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">11</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">4</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.25</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4fe529e952cd90bab468ade2156ac68f28c801a2bf07d7208fbcc25f079e3d8c" target="_blank" rel="noopener noreferrer">Cybin: Upgrade To Hold - But Don't Get Too Carried Away</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-11</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.34
                                </span>
                            </div>
                            <div class="article-summary">Cybin has made steady progress but faces major hurdles, with its stock swayed by sector sentiment. Read why CYBN stock is upgraded to hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bae0c30c48760ffb7c95e02733eb1a4a66545a4172adca2dd54ef032834223c0" target="_blank" rel="noopener noreferrer">Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8: 00am ET</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.41
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in a fireside......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f0436231d41121d9a101a9df678e979c71250d3a81a775c3f7b1e709a5bec7d3" target="_blank" rel="noopener noreferrer">Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, July 10, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that manag...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b8e75ba1c7241b1a9ed1112ddb24801198e4caed91ab45aaf15f514e9fef7cda" target="_blank" rel="noopener noreferrer">COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">COMPASS Pathways (CMPS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=171a9f93b09e7671c763d31222e62b915fcf0df3bdafdc8e5073d03a8043cd1f" target="_blank" rel="noopener noreferrer">Weekly Roundup on the Cannabis Sector & Psychedelic Sector</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.31
                                </span>
                            </div>
                            <div class="article-summary">Key Takeaways; Cannabis Sector Weedmaps co-founders withdrew buyout offer, but left door open for future deal High Tide launched “Buy Local” cannabis campaign across Canada to celebrate Canada Day Til...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=610cd940cce410c41a402f334ea9aa7b6579f09d932673c9958536d1e0b4351f" target="_blank" rel="noopener noreferrer">COMPASS Pathways : 2025 AGM Voting Results</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-30</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">COMPASS Pathways plc Results of 2025 Annual General Meeting of Shareholders COMPASS Pathways plc held its Annual General Meeting at 1:30 p.m. London time on......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=228db96a640c880762b18f69a6d3ad70f06f4aad28f290bcefc530ebef97926a" target="_blank" rel="noopener noreferrer">This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.52
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways took a 50% on June 23 hit after a lukewarm trial, but long-term bulls see upside in psychedelics....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e7472f28c5d499e0418b44d9116f21dd4e3d74d27cb4c24bbb8e5395d0d90c82" target="_blank" rel="noopener noreferrer">Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.79
                                </span>
                            </div>
                            <div class="article-summary">In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a primary endpoint achievement, a clinical site addition and additional development ca...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bfe74836ee48b9fa551d30c53bd8ed9fcd927ba4b769af94116c83777445e889" target="_blank" rel="noopener noreferrer">Compass Pathways: Psychedelics Drug Data Sends Share Price South - Rating Downgrade</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-25</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.39
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c1cd9473b887d90097931ffe0c94927fb3fc5b1e5c1612cd8caf1aea8e39f6d1" target="_blank" rel="noopener noreferrer">Compass’ stock slips despite psilocybin trial hitting target</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.37
                                </span>
                            </div>
                            <div class="article-summary">Compass is running another Phase III trial of its psilocybin candidate, which is due to readout in H2 2026....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=813db7288fcf712d169cdf3c29e9b1c06a9330b0ec08902c106032272929334d" target="_blank" rel="noopener noreferrer">Compass Pathways Stock: Downgrading To Hold On Released TRD Results With COMP360</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-24</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways plc downgraded to Hold after mixed trial results. Explore upcoming catalysts in depression treatment and market trends. Click for my CMPS update....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d681b239957df20ad9e76985472240dcf1bf6b729d3f84431db8bea195ad1629" target="_blank" rel="noopener noreferrer">Compass Pathways' depression drug succeeds late-stage trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.59
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways said onMonday its experimental psilocybin-based therapy helpedsignificantly reduce symptoms of difficult-to-treat depressionin a late-stage study.(Reporting by Mariam Sunny and......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1870ca06c8fe6f837bfd8cbe1d6a6a8ae6b68bc471f87876d281939580f7de8f" target="_blank" rel="noopener noreferrer">COMPASS Pathways : investor presentation June 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Transforming Mental Health Care ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a078e9921b286f7c144eaea392538cf100b69df125cc855fb23fa8df783de3ce" target="_blank" rel="noopener noreferrer">Compass shares tumble after depression drug fails to impress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.17
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways'psilocybin-based depression therapy showed statistically significant benefits in a late-stagestudy on Monday, although it fell short of market expectations,sending......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d87289d3dd5bd92cf7605acfbfa0487fbbf0e0d407496de3820a4d0403ca894a" target="_blank" rel="noopener noreferrer">Compass Pathways' depression drug meets main goal in late-stage trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.72
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways said onMonday its experimental psilocybin-based therapy helpedsignificantly reduce the symptoms of difficult-to-treatdepression in a late-stage study. The study,......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=06253974154467699fcc037a807eb5c0633173696cae88b012c175cf46cb4503" target="_blank" rel="noopener noreferrer">Compass Pathways plc Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.93
                                </span>
                            </div>
                            <div class="article-summary">Compass Pathways plc announced the successful achievement of the primary endpoint in the ongoing Phase 3 COMP005 trial, the first of two Phase 3 trials evaluating COMP360, a synthetic, proprietary......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c1a281d1235ca63479982c73c8edeb52251fe2f4bbac73d3d2723553ae93dcff" target="_blank" rel="noopener noreferrer">Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">LONDON & NEW YORK, June 23, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful ach...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c1fd0c21075e679fdbf893541dfc941f90f39ede84b043afc88ab8119ada0de5" target="_blank" rel="noopener noreferrer">Compass’ big psychedelic study doesn’t impress investors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.43
                                </span>
                            </div>
                            <div class="article-summary">While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s version of psilocybin could be as a depression treatment....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=008d12e2bc2a23b4542f3f9707e07b525d075b4874a22a4c0e2b3342a2148f69" target="_blank" rel="noopener noreferrer">Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-23</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.47
                                </span>
                            </div>
                            <div class="article-summary">(Bloomberg) -- Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a late-stage trial.Most Read from BloombergBezos Wedding Draws...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7c4dfe31736510c7322e16d44c6239e93e3a232a1b30bc23fa97e7a5262b3326" target="_blank" rel="noopener noreferrer">Psychedelic advocates hopeful Trump administration will support space, STAT says</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.77
                                </span>
                            </div>
                            <div class="article-summary">Companies, advocates and investors in the psychedelic field are hopeful the Trump administration will support the space after favorable sentiments by several key officials, STAT News’ Olivia Goldhill ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f9b18d6d502f4174efdb1675c6cb1394a78b09ebbc0a76e2ff74eb8119e3385e" target="_blank" rel="noopener noreferrer">Trump Trade: President said to weigh possible U.S. strike against Iran</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-19</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fl...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=346122f20f4e80d75aa5f3c49882779d6c58a148eb5e74d00cdcb90c085e6077" target="_blank" rel="noopener noreferrer">Psyence BioMed Chief of Global Impact to Speak at Psychedelic Science 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-18</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Investors, Entrepreneurs, and Industry Experts to Convene at the Premier Psychedelic Science Business Forum hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) Denver, Colorado--(Ne...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        